Common Stock SEC Reporting - Current
Verified Company Profile 5/01/2017
Contact Info
  • 2600 Kelly Road
  • Suite 100
  • Warrington, PA 18976

Business Description

Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Jun 30, 2017 10-Q
CIK 0000946486
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2836 - Biological products, except diagnostic
Incorporated In: DE, USA
Year of Inc. 1992
Employees 49 a/o Jan 01, 2017
Company Officers/Contacts
Craig E. Fraser CEO
John A. Tattory CFO, Senior VP
Mary B. Templeton, Esq. Senior VP, General Counsel
Steven G. Simonson, MD Senior VP, Chief Med. Officer
Kathryn A. Cole VP, Human Res., Senior VP
George Cox VP, Manufacturing
Lawrence A. Weinstein Vice President
Kathleen W. Fitzgibbon Director, Legal Svcs.
Company Directors
John R. Leone Chairman
Craig E. Fraser
Joseph M. Mahady
Bruce A. Peacock
Marvin E. Rosenthale, Ph.D.
Company Notes
  • Formerly=Discovery Laboratories, Inc. until 4-2016
  • Formerly=Ansan Pharmaceuticals, Inc. until 11-97
  • Note=11-97 company is a development stage pharmaceutical company
Service Providers
Accounting/Auditing Firm
Ernst & Young LLP
One Commerce Square
2005 Market Street
Suite 700
Philadelphia, PA, 19103
United States

Legal Counsel
Denton US LLP
809 Glen Eagles Court
New York, NY, 10020
United States

Investor Relations Firm
WINT Security Details
Share Structure
Market Value1 $2,703,826 a/o Sep 20, 2017
Authorized Shares 60,000,000 a/o Apr 07, 2017
Outstanding Shares 13,994,960 a/o Aug 15, 2017
-Restricted 82,118 a/o Apr 07, 2017
-Unrestricted Not Available
Held at DTC Not Available
Float 9,551,161 a/o Apr 07, 2017
Par Value Not Available
Transfer Agent(s) Verified by Transfer Agent
Continental Stock Transfer & Trust Company
Shareholders of Record 104 a/o Mar 23, 2016
Short Selling Data
Short Interest 57,793 (-15.6%)
Aug 31, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security